Sign in

CIK 0001739410 · <br>Emerging growth company

Rallybio Corp

Sign in to watch
Ticker
RLYB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851083789
Phone
203- 859-3820
Business address
234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
Former names
Rallybio Holdings, LLC
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 425 Deal Prospectus/Communication re Business Combination
  3. 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
  4. 4 Open-market buy 10% owner bought 16,209 shares at an average $13.98 ($226,563)
  5. 4 Open-market buy 10% owner bought 79,559 shares at an average $13.99 ($1,112,977)
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 4 Open-market buy 10% owner bought 50,800 shares at an average $14.00 ($711,055)
  11. 10-Q Report Quarterly Report
  12. 4 Open-market buy 10% owner bought 155,905 shares at an average $13.97 ($2,178,668)
  13. 3 Insider Initial Statement of Ownership
  14. SCHEDULE 13D/A Stake Beneficial Ownership Report
  15. RW Other RW
  16. 8-K Event Agreement ended
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. S-4/A Deal Registration Statement - Business Combination
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 8-K Event Executive or director change

Page 3 of 16 · 312 filings